₹237.10-8.20 (-3.34%)
04:01 PM, 9-Jan-2025₹237.15-8.55 (-3.48%)
03:54 PM, 9-Jan-2025BSE : 543635
NSE : PPLPHARMA
Sector : Health care
ISIN Code : INE0DK501011
Last Updated: 09-Jan-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 31,434 |
Traded Value (₹ Cr) | 2.96 |
Volume (Shares) | 1,24,866 |
Face Value (₹) | 10 |
52-Week High (₹) | 307.85 |
52-Week High Date | 06-Nov-2024 |
52-Week Low (₹) | 114.45 |
52-Week Low Date | 15-Mar-2024 |
All Time High (₹) | 307.85 |
All Time High Date | 06-Nov-2024 |
All Time Low (₹) | 61.65 |
All Time Low Date | 28-Mar-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 31,440 |
EPS - TTM (₹) [C] | 0.44 |
P/E Ratio (X) [C] | 538.98 |
Face Value (₹) | 10 |
Latest Dividend (%) | 1.10 |
Latest Dividend Date | 12-Jul-2024 |
Dividend Yield (%) | 0.05 |
Book Value Share (₹) [C] | 59.66 |
P/B Ratio (₹) [C] | 3.98 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Flexi Cap Fund - (IDCW) | 1928.07 | 7,24,15,688 | 2.91 |
HDFC Flexi Cap Fund - (G) | 1928.07 | 7,24,15,688 | 2.91 |
HDFC Flexi Cap Fund - Direct (IDCW) | 1928.07 | 7,24,15,688 | 2.91 |
HDFC Flexi Cap Fund - Direct (G) | 1928.07 | 7,24,15,688 | 2.91 |
HDFC Focused 30 Fund (G) | 559.13 | 2,10,00,000 | 3.57 |
HDFC Focused 30 Fund (IDCW) | 559.13 | 2,10,00,000 | 3.57 |
HDFC Focused 30 Fund - Direct (IDCW) | 559.13 | 2,10,00,000 | 3.57 |
HDFC Focused 30 Fund - Direct (G) | 559.13 | 2,10,00,000 | 3.57 |
Canara Robeco Small Cap Fund - Regular (G) | 133.49 | 50,13,811 | 1.06 |
Canara Robeco Small Cap Fund - Regular (IDCW) | 133.49 | 50,13,811 | 1.06 |
Load more
Today's Low/High (₹) | 233.30 251.15 |
Week Low/High (₹) | 233.30 263.00 |
Month Low/High (₹) | 233.30 273.00 |
Year Low/High (₹) | 114.35 308.00 |
All time Low/High (₹) | 61.65 308.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -7.85% | -7.83% | -2.91 | -2.74% |
1 Month | -7.27% | -7.22% | -4.77 | -4.44% |
3 Month | 5.85% | 5.82% | -4.72 | -5.83% |
6 Month | 52.31% | 52.24% | -3.40 | -3.71% |
1 Year | 65.96% | 65.61% | 8.73 | 9.20% |
3 Year | % | % | 29.92 | 32.08% |
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Non Executive Director : Neeraj Bharadwaj
Independent Director : Jairaj Purandare
Independent Director : S Rama Dorai
Independent Director : Peter Stevenson
Independent Director : Sridhar Gorthi
Independent Director : Vibha Paul Rishi
Executive Director & CFO : Vivek Valsaraj
Company Sec. & Compli. Officer : Tanya D'Costa
Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000
1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 237.10 at 04:01 PM IST on 9th Jan 2025. Piramal Pharma Ltd share price was down by 3.34% from the previous closing price of Rs 245.30. Piramal Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 31,434 crore.
4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 307.85 and 52-week low share price is Rs 114.45.
5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a profit of Rs 210.06 crore on a total income of Rs 1,390.77 crore for the quarter ended 2024. For the year ended Sep 2024, Piramal Pharma Ltd had posted a profit of Rs 22.59 crore on a total income of Rs 2,320.12 crore.
6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are Glaxosmi. Pharma, Ajanta Pharma, Laurus Labs, Piramal Pharma, Gland Pharma, J B Chemicals &, Suven Pharma.
7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows: